Page 22 - CIRN Annual Report 2017

The manuscript describing the measles test validation was recently
project received leveraged funds from PHAC to conduct a study of
rubella serostatus in pregnant women (MIREC biobank) which was
practitioners, and scientists, to assess VPD serostatus in Canada.
completed in early 2017. The manuscript describing this work has
disease (VPD) immune status, for use by public health agencies,
rubella using inexpensive, commercially-available reagents. This
varicella immunity that were not previously available in Canada.
low-volume, high-throughput assays for measles, mumps and
antibody determination while the other group has established
One group is in the process of developing an assay for polio
enzyme immunoassays and reference tests for measles and
Development of critical tools to assess vaccine preventable
published in Clinical and Vaccine Immunology.

Reference Laboratory Network (RLN)

been accepted at Vaccine.

collected in CIRN studies, keeping these accessible for future CIRN

The Reference Laboratory Network (RLN) manages the
sample archive comprising sera and other biological material

studies. The sero-epidemiology group is conducting three national studies to estimate Population immunity to varicella, measles and mumps in Canada. The goal is to measure the impact of Canada’s immunization programs and to determine the risk of future outbreaks. These studies will generate essential data to inform public health and policy decision-making about varicella and mumps control and measles elimination. Having obt